Li D - Search Results

1

Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.

Stein DJ, Westenberg HG, Yang H, Li D, Barbato LM. Stein DJ, et al. Among authors: li d. Int J Neuropsychopharmacol. 2003 Dec;6(4):317-23. doi: 10.1017/S146114570300364X. Int J Neuropsychopharmacol. 2003. PMID: 14604447 Free article. Clinical Trial.

2

A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder.

Westenberg HG, Stein DJ, Yang H, Li D, Barbato LM. Westenberg HG, et al. Among authors: li d. J Clin Psychopharmacol. 2004 Feb;24(1):49-55. doi: 10.1097/01.jcp.0000104906.75206.8b. J Clin Psychopharmacol. 2004. PMID: 14709947 Clinical Trial.

3

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM. Hollander E, et al. Among authors: li d. J Clin Psychiatry. 2003 Jun;64(6):640-7. doi: 10.4088/jcp.v64n0604. J Clin Psychiatry. 2003. PMID: 12823077 Clinical Trial.

4

Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder.

Davidson J, Yaryura-Tobias J, DuPont R, Stallings L, Barbato LM, van der Hoop RG, Li D. Davidson J, et al. Among authors: li d. J Clin Psychopharmacol. 2004 Apr;24(2):118-25. doi: 10.1097/01.jcp.0000106222.36344.96. J Clin Psychopharmacol. 2004. PMID: 15206657 Clinical Trial.

5

Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder.

Hollander E, Kaplan A, Schmeidler J, Yang H, Li D, Koran LM, Barbato LM. Hollander E, et al. Among authors: li d. J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):472-7. doi: 10.1176/jnp.17.4.472. J Neuropsychiatry Clin Neurosci. 2005. PMID: 16387985 Clinical Trial.

6

Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study.

van der Heijde D, Deodhar A, Wei JC, Drescher E, Fleishaker D, Hendrikx T, Li D, Menon S, Kanik KS. van der Heijde D, et al. Among authors: li d. Ann Rheum Dis. 2017 Aug;76(8):1340-1347. doi: 10.1136/annrheumdis-2016-210322. Epub 2017 Jan 27. Ann Rheum Dis. 2017. PMID: 28130206 Free PMC article. Clinical Trial.

7

Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients.

Maksymowych WP, van der Heijde D, Baraliakos X, Deodhar A, Sherlock SP, Li D, Fleishaker D, Hendrikx T, Kanik KS. Maksymowych WP, et al. Among authors: li d. Rheumatology (Oxford). 2018 Aug 1;57(8):1390-1399. doi: 10.1093/rheumatology/key104. Rheumatology (Oxford). 2018. PMID: 29718421 Free PMC article. Clinical Trial.

8

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN; Step Study Protocol Team. Buchbinder SP, et al. Among authors: li d. Lancet. 2008 Nov 29;372(9653):1881-1893. doi: 10.1016/S0140-6736(08)61591-3. Epub 2008 Nov 13. Lancet. 2008. PMID: 19012954 Free PMC article. Clinical Trial.

9

Engineering the Methylerythritol Phosphate Pathway and Using a Temporal Promoter for Enhanced Lycopene Production in Rhodobacter sphaeroides HY01.

He X, Wang D, Liu J, Shi T, Wang W, Chen B, Li D, Zhang L, Tan GY. He X, et al. Among authors: li d. J Agric Food Chem. 2024 Dec 3. doi: 10.1021/acs.jafc.4c07848. Online ahead of print. J Agric Food Chem. 2024. PMID: 39626274

10

Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.

George TJ, Lee JH, DeRemer DL, Hosein PJ, Staal S, Markham MJ, Jones D, Daily KC, Chatzkel JA, Ramnaraign BH, Close JL, Ezenwajiaku N, Murphy MC, Allegra CJ, Rogers S, Zhang Z, Li D, Srinivasan G, Shaheen M, Hromas R. George TJ, et al. Among authors: li d. JCO Precis Oncol. 2024 Dec;8:e2400406. doi: 10.1200/PO-24-00406. Epub 2024 Dec 3. JCO Precis Oncol. 2024. PMID: 39626160 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,282 results

Search Page

Filters